1. Review on the molecular signaling pathways involved in controlling cancer stem cells and treatment
   Flora Forouzesh et al, 2018, The Journal of Qazvin University of Medical Sciences CrossRef
2. Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance
   Xinzhi Miao et al, 2021, 3 Biotech CrossRef
3. The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells
   Ning An et al, 2020, Pathology & Oncology Research CrossRef
4. Advances in research of extracellular mechanisms underlying gemcitabine resistance in pancreatic cancer
   Zong-Ting Gu et al, 2021, World Chinese Journal of Digestology CrossRef
5. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs
   Yiwei Li et al, 2021, Cancers CrossRef
6. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma
   Jorge Melendez-Zajgla et al, 2021, International Journal of Molecular Sciences CrossRef
7. Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis
   Daolin Ji et al, 2022, Journal of Oncology CrossRef
8. Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene Via Maintaining Mitochondrial Function in Pancreatic Cancer
   Li Wang et al, 2022, Frontiers in Genetics CrossRef
9. Extracellular Vesicle-Loaded Oncogenic lncRNA NEAT1 from Adipose-Derived Mesenchymal Stem Cells Confers Gemcitabine Resistance in Pancreatic Cancer via miR-491-5p/Snail/SOCS3 Axis
   Rongxiang Wu et al, 2023, Stem Cells International CrossRef